JK

John Kelly

Tetratherix Limited | Non-Executive Director
Mr Kelly has experience in the medical device industry, including product development, manufacturing and regulatory approval. He previously led the development of a rapid test platform and was involved in securing regulatory approvals and an initial public offering. Prior to that, John held a Chief Operating Officer role where he was involved in the development of drug delivery devices.

Company and Role

Company
Title
Tenure
Since
TTX
Tetratherix Limited
  • Non-Executive Director
1yrs, 4mthMay 2025

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
TTX
Tetratherix Limited
30/06/2612,013N/AN/AN/A
30/06/258,991,87065,120,0001,621,622N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
27/06/25
Issued
1,621,622$0.018$30,000Issue of securities
27/06/25
Issued
1,621,622$0.015$24,324Issue of securities
14/04/25
Expiry
666,666$0.022$14,666Options expired
03/08/23
Expiry
666,666$0.030$19,999Options expired
27/10/22
Issued
666,666$0.020$13,333Issue of options